Jose Gerard Monzon
92 works · 1,707 citations · h-index 21
Top works
- CDKN2AMutations in Multiple Primary Melanomas
- Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma
- A phase 2 study of tremelimumab in patients with advanced uveal melanoma
- Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma
- Successful Treatment of Cytokine Release Syndrome with IL-6 Blockade in a Patient Transitioning from Immune-Checkpoint to MEK/BRAF Inhibition: A Case Report and Review of Literature
- Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer
- Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study
- Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy
- Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation
- Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer
- Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers
- Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials
- Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients
- Ridaforolimus: A Promising Drug in the Treatment of Soft-Tissue Sarcoma and Other Malignancies
- Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer
- Role of the Cyclin-Dependent Kinase Inhibitor CDKN2A in Familial Melanoma
- Canadian Cohort Expanded-Access Program of Nivolumab Plus Ipilimumab in Advanced Melanoma
- CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines
- Acute liver failure and seizures as a consequence of regorafenib exposure in advanced rectal cancer
- Adjuvant Systemic Therapies for Resected Stages III and IV Melanoma: A Multi-Center Retrospective Clinical Study